Mclaughlin Research Institute For Biomedical Sciences
- Assets
- $13.4m
- Revenue
- $3.7m
- Investments
- $960.1k
- Employees
- 23
- Location
- Great Falls, MT
- Founding
- 10/1994
- Data as of
- 06/2021
- EIN
- 81-0459235
Organization Overview
Mclaughlin Research Institute For Biomedical Sciences, operating under the name Mclaughlin Research Institute, is located in Great Falls, MT. The organization was established in 1994. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. As of 06/2021, Mclaughlin Research Institute employed 23 individuals. This organization is an itermediate organization (such as a geographic headquarters) for a national or regional group of organizations. Mclaughlin Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2021, Mclaughlin Research Institute generated $3.7m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 3.9% each year. All expenses for the organization totaled $2.4m during the year ending 06/2021. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE INSTITUTE'S MISSION IS TO IMPROVE HUMAN HEALTH THROUGH INNOVATIVE GENETIC RESEARCH AND EDUCATION.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DURING FISCAL YEAR 2021, THE INSTITUTE SCIENTISTS AND STAFF CONTINUED THEIR EFFORTS TO BETTER UNDERSTAND THE CELLULAR AND MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASE PROCESSES THROUGH INNOVATIVE GENETIC APPROACHES IN MURINE MODELS WHILE EXPANDING THE PROGRAM OF TRANSLATIONAL RESEARCH, SUPPLEMENTING TREATMENT ADVANCES. THE RESEARCH FOCUSED LARGELY ON THE MECHANISMS BEHIND THE PROPAGATION OF PROTEIN MISFOLDING IN DISEASES SUCH AS FRONTOTEMPORAL DEMENTIA, ALZHEIMER'S AND PRION DISEASES, AS WELL AS NOVEL TREATMENT APPROACHES. SUCH WORK INCLUDED PARTNERSHIPS WITH UP TO TEN COLLABORATORS AND 25 PROJECTS AMONG INVESTIGATORS WITH PARTNERSHIPS EXTENDING NATIONALLY TO NEW YORK, WASHINGTON, MASSACHUSETTS, NORTH CAROLINA AND MONTANA INCLLUDING SUBAWARDS CONTRIBUTING TO $107,000 IN GRANTS AND $692,000 IN ADDITIONAL CONTRACTS. EFFORTS CONTINUED TOWARDS UNDERSTANDING HUNTINGTON'S DISEASE IN COLLABORATION WITH INVESTIGATORS FROM WESTERN WASHINGTON UNIVERSITY AND THE CURE HUNTINGTON'S DISEASE FOUNDATION; AS WELL AS MAKING STRIDES ON INVESTIGATOR LED STUDIES AND FUTURE FUNDING OPPORTUNITIES WITH THE NATIONAL INSTITUTES OF HEALTH. INVESTIGATORS CONTINUED CRITICAL WORK AND NEW TREATMENT DEVELOPMENT SCREENING IN COLLABORATION WITH SEVERAL PHARMACEUTICAL COMPANIES AND TOOK TO NEW DIRECTIONS IN COLLABORATION WITH THE BELIEVE IN A CURE FOUNDATION FOCUSED ON ORPHAN DISEASE REASEARCH FOR FOXG1 SYNDROME. THE INSTITUTE CONTINUED THE EFFORTS OF THE NIH FUNDED GRANT (AWARDED MARCH 2018) IN THE AMOUNT OF $405,000/YEAR FOR FIVE YEARS TO GAIN INSIGHT ON NEUROTRANSMITTERS ELECTROPHYSIOLOGY IN NEURODEGENERATIVE DISEASES. TOTALING 1.75 MILLION WERE RECEIEVED BY THE INSTITUTE THAT INCLUDED A FUNDING MATCH CAMPAIGN OF $980,000 AIMED AT THE SUCCESSFUL RECRUITMENT OF A NEW DIRECTOR. THIS WAS ACCOMPLISHED IN EARLY 2021 ULTIMATELY WELCOMING AN ADDITIONAL SCIENTIST AND ADDITIONAL NIH FUNDED RESEARSCH BEGINNING AT $15,000.
THE INSTITUTE POSTPONED THE SUMMER INTERNSHIP PROGRAM DUE TO COVID-19 PANDEMIC BUT WAS ABLE TO $5200 FOR FUTURE INTERN SCHOLORSHIPS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Teresa Gunn Associate Professor | 40 | $114,964 | |
Michael Kavanaugh PHD Director | Officer | 20 | $92,550 |
Maria Knapek Fin And Res Sup Officer | Officer | 40 | $88,600 |
Randy Gray Chair | OfficerTrustee | 5 | $0 |
Maxon Davis Vice-President | OfficerTrustee | 1 | $0 |
John Lane Secretary | OfficerTrustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $556,071 |
| All other contributions, gifts, grants, and similar amounts not included above | $1,991,448 |
| Noncash contributions included in lines 1a–1f | $650,512 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $2,547,519 |
| Total Program Service Revenue | $694,299 |
| Investment income | $97,399 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $353,711 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $3,697,613 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $4,500 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $296,114 |
| Compensation of current officers, directors, key employees. | $107,110 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $688,242 |
| Pension plan accruals and contributions | $86,938 |
| Other employee benefits | $141,477 |
| Payroll taxes | $74,301 |
| Fees for services: Management | $2,504 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $9,074 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $36,388 |
| Fees for services: Other | $62,298 |
| Advertising and promotion | $8,690 |
| Office expenses | $20,020 |
| Information technology | $37,645 |
| Royalties | $0 |
| Occupancy | $242,883 |
| Travel | $23,315 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $253 |
| Interest | $5,071 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $342,847 |
| Insurance | $34,030 |
| All other expenses | -$81 |
| Total functional expenses | $2,360,443 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,965,669 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $481,022 |
| Accounts receivable, net | $285,092 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $31,539 |
| Prepaid expenses and deferred charges | $19,207 |
| Net Land, buildings, and equipment | $5,840,075 |
| Investments—publicly traded securities | $3,861,517 |
| Investments—other securities | $960,141 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $3,550 |
| Total assets | $13,447,812 |
| Accounts payable and accrued expenses | $59,531 |
| Grants payable | $0 |
| Deferred revenue | $401,040 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $49,337 |
| Unsecured mortgages and notes payable | $208,997 |
| Other liabilities | $167,427 |
| Total liabilities | $886,332 |
| Net assets without donor restrictions | $8,754,233 |
| Net assets with donor restrictions | $3,807,247 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $13,447,812 |